ABBOTT LABORATORIES — Director's Dealing 2022

Mar 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2022-02-28

Reporting Person: Funck, Jr. Robert E. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-28	Common shares without par value	F	10750	$122.41	Disposed	206582	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	10000	Indirect
Common shares without par value	10000	Indirect
Common shares without par value	18085	Indirect
Common shares without par value	500	Indirect

Footnotes

F1: Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2022.

F3: The reporting person disclaims beneficial ownership of all securities held by his daughter.